Acquisition of Various Medicines (Genitourinary Respiratory System Medicines), under AQ 20237495 for the 2026 Financial Year

This tender is for the acquisition of various medicines, specifically those for the Genitourinary and Respiratory systems, for the 2026 financial year. The procurement is being conducted under Framework Agreement (AQ) number 20237495. This indicates that the contracting authority is leveraging an existing framework agreement to streamline the procurement process for these essential pharmaceutical products. The scope includes a range of medications used to treat conditions affecting the urinary tract, reproductive system, and respiratory system. The objective is to ensure a consistent and adequate supply of these critical medicines to meet the healthcare needs of the population served by the procuring entity, which could be a public health service, hospital, or government agency. By utilizing the framework agreement, the process is likely more efficient and potentially offers better pricing. The tender will specify the exact list of medicines, required quantities, dosage forms, packaging, and delivery schedules. Ensuring the availability of these specific drug categories is vital for patient treatment and public health management.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 818.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.